Edition:
United States

Biotechnology & Medical Research

FDA gives "orphan drug" status to Idera's skin cancer drug

June 22 (Reuters) - Idera Pharmaceuticals Inc -:Idera announces FDA orphan drug designation for IMO-2125 for the treatment of melanoma.Idera Pharmaceuticals Inc - expects to complete enrollment of phase 2 multicenter trial in h2 2017, overall response rate data available in q1 of 2018.Idera...

4:30pm EDT

Ionis Pharmaceuticals entered into agreements with affiliates of Biomed Realty L.P

June 22 (Reuters) - Ionis Pharmaceuticals Inc :On June 19, co entered into agreements with affiliates of Biomed Realty L.P - SEC filing.Ionis Pharmaceuticals - ‍pursuant to which co will purchase real property located at 2855 Gazelle Court, Carlsbad, California for purchase price of $79.4...

4:03pm EDT

Stonepine Capital Management LLC reports 7.6 pct passive stake in CTI Biopharma Corp as of June 6, 2017

June 22 (Reuters) - Stonepine Capital Management LLC :Stonepine Capital Management LLC reports 7.6 percent passive stake in cti biopharma corp as of june 6, 2017 - SEC filing.

1:44pm EDT

Diasorin signs collaboration with QIAGEN to expand LIAISON test menu

June 22 (Reuters) - DIASORIN SPA ::SIGNS COLLABORATION WITH QIAGEN TO DEVELOP NEW TESTS FOR DIASORIN’S LIAISON FAMILY OF ANALYZERS BASED ON REVIEW AND SELECTION PROCESS INVOLVING QIAGEN’S ASSAY TECHNOLOGIES.

11:58am EDT

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.